Atea Pharmaceuticals Statistics
Total Valuation
AVIR has a market cap or net worth of $245.46 million. The enterprise value is -$207.62 million.
Important Dates
The next estimated earnings date is Tuesday, May 13, 2025, after market close.
| Earnings Date | May 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
AVIR has 85.53 million shares outstanding. The number of shares has increased by 1.05% in one year.
| Current Share Class | 85.53M |
| Shares Outstanding | 85.53M |
| Shares Change (YoY) | +1.05% |
| Shares Change (QoQ) | +0.05% |
| Owned by Insiders (%) | 13.52% |
| Owned by Institutions (%) | 59.10% |
| Float | 66.36M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.55 |
| P/TBV Ratio | 0.56 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 24.85, with a Debt / Equity ratio of 0.00.
| Current Ratio | 24.85 |
| Quick Ratio | 24.44 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -33.88% and return on invested capital (ROIC) is -16.56%.
| Return on Equity (ROE) | -33.88% |
| Return on Assets (ROA) | -15.60% |
| Return on Invested Capital (ROIC) | -16.56% |
| Return on Capital Employed (ROCE) | -29.64% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$3.01M |
| Employee Count | 56 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, AVIR has paid $925,000 in taxes.
| Income Tax | 925,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -23.86% in the last 52 weeks. The beta is 0.17, so AVIR's price volatility has been lower than the market average.
| Beta (5Y) | 0.17 |
| 52-Week Price Change | -23.86% |
| 50-Day Moving Average | 3.00 |
| 200-Day Moving Average | 3.32 |
| Relative Strength Index (RSI) | 47.59 |
| Average Volume (20 Days) | 404,918 |
Short Selling Information
The latest short interest is 3.01 million, so 3.52% of the outstanding shares have been sold short.
| Short Interest | 3.01M |
| Short Previous Month | 2.91M |
| Short % of Shares Out | 3.52% |
| Short % of Float | 4.54% |
| Short Ratio (days to cover) | 10.81 |
Income Statement
| Revenue | n/a |
| Gross Profit | -83.37M |
| Operating Income | -132.22M |
| Pretax Income | -174.95M |
| Net Income | -168.39M |
| EBITDA | -131.80M |
| EBIT | -132.22M |
| Earnings Per Share (EPS) | -$2.00 |
Full Income StatementBalance Sheet
The company has $454.72 million in cash and $1.64 million in debt, giving a net cash position of $453.08 million or $5.30 per share.
| Cash & Cash Equivalents | 454.72M |
| Total Debt | 1.64M |
| Net Cash | 453.08M |
| Net Cash Per Share | $5.30 |
| Equity (Book Value) | 438.87M |
| Book Value Per Share | 5.20 |
| Working Capital | 443.75M |
Full Balance SheetCash Flow
| Operating Cash Flow | -135.50M |
| Capital Expenditures | n/a |
| Free Cash Flow | -135.50M |
| FCF Per Share | -$1.58 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |